Private equity firm SK Capital (New York) has raised $500 million for a new fund targeting investments in the chemicals, specialty materials, and healthcare sectors. SK says the funds raised exceeded its initial target by $100 million. "We believe the volatile macroeconomic backdrop will provide fertile ground to execute our strategy," says Barry Siadat, managing director, SK Capital.
展开▼
机译：私募股权公司SK Capital（纽约）已筹集了5亿美元用于针对化学，特种材料和医疗保健领域的投资的新基金。 SK表示，筹集的资金超出了其最初的目标1亿美元。 SK Capital董事总经理Barry Siadat说：“我们相信，动荡的宏观经济背景将为执行我们的战略提供沃土。”
展开▼
